These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 20456356

  • 1. A critical evaluation of cryoprecipitate for replacement of fibrinogen.
    Sørensen B, Bevan D.
    Br J Haematol; 2010 Jun; 149(6):834-43. PubMed ID: 20456356
    [Abstract] [Full Text] [Related]

  • 2. Cryoprecipitate: no longer the best therapeutic choice in congenital fibrinogen disorders?
    Bevan DH.
    Thromb Res; 2009 Dec; 124 Suppl 2():S12-6. PubMed ID: 20109651
    [Abstract] [Full Text] [Related]

  • 3. Comparison of coagulation factor XIII content and concentration in cryoprecipitate and fresh-frozen plasma.
    Caudill JS, Nichols WL, Plumhoff EA, Schulte SL, Winters JL, Gastineau DA, Rodriguez V.
    Transfusion; 2009 Apr; 49(4):765-70. PubMed ID: 19192257
    [Abstract] [Full Text] [Related]

  • 4. Restoring hemostasis: fibrinogen concentrate versus cryoprecipitate.
    Elliott BM, Aledort LM.
    Expert Rev Hematol; 2013 Jun; 6(3):277-86. PubMed ID: 23782082
    [Abstract] [Full Text] [Related]

  • 5. Fibrinogen concentrate for acquired hypofibrinogenaemic states.
    Weinkove R, Rangarajan S.
    Transfus Med; 2008 Jun; 18(3):151-7. PubMed ID: 18598277
    [Abstract] [Full Text] [Related]

  • 6. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
    Rahe-Meyer N, Solomon C, Winterhalter M, Piepenbrock S, Tanaka K, Haverich A, Pichlmaier M.
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):694-702. PubMed ID: 19698858
    [Abstract] [Full Text] [Related]

  • 7. In vitro comparative study of hemostatic components in warfarin-treated and fibrinogen-deficient plasma.
    Rumph B, Bolliger D, Narang N, Molinaro RJ, Levy JH, Szlam F, Tanaka KA.
    J Cardiothorac Vasc Anesth; 2010 Jun; 24(3):408-12. PubMed ID: 19819728
    [Abstract] [Full Text] [Related]

  • 8. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD, Ninivaggi M, Schols SE, Feijge MA, Oehrl SK, Kuiper GJ, Nikiforou M, Marcus MA, Hamulyak K, van Pampus EC, ten Cate H, Heemskerk JW.
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [Abstract] [Full Text] [Related]

  • 9. Results of an international, multicentre pharmacokinetic trial in congenital fibrinogen deficiency.
    Peyvandi F.
    Thromb Res; 2009 Dec; 124 Suppl 2():S9-11. PubMed ID: 20109654
    [Abstract] [Full Text] [Related]

  • 10. Observational study of fibrinogen concentrate in massive hemorrhage: evaluation of a multicenter register.
    Weiss G, Lison S, Glaser M, Herberger S, Johanning K, Strasser T, Huber T, Spannagl M, Heindl B.
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):727-34. PubMed ID: 22024795
    [Abstract] [Full Text] [Related]

  • 11. Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.
    Rahe-Meyer N, Hanke A, Schmidt DS, Hagl C, Pichlmaier M.
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3 Suppl):S178-85. PubMed ID: 23410777
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.
    Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sørensen B.
    Br J Anaesth; 2008 Dec; 101(6):769-73. PubMed ID: 18818192
    [Abstract] [Full Text] [Related]

  • 13. Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution.
    Fenger-Eriksen C, Christiansen K, Laurie J, Sørensen B, Rea C.
    Thromb Res; 2013 May; 131(5):e210-3. PubMed ID: 23473642
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen concentrate in the treatment of severe bleeding after aortic aneurysm graft surgery.
    Rahe-Meyer N.
    Thromb Res; 2011 May; 128 Suppl 1():S17-9. PubMed ID: 22221846
    [Abstract] [Full Text] [Related]

  • 15. Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding.
    Levy JH, Szlam F, Tanaka KA, Sniecienski RM.
    Anesth Analg; 2012 Feb; 114(2):261-74. PubMed ID: 21965371
    [Abstract] [Full Text] [Related]

  • 16. Plasma-derived biological medicines used to promote haemostasis.
    Ofosu FA, Freedman J, Semple JW.
    Thromb Haemost; 2008 May; 99(5):851-62. PubMed ID: 18449414
    [Abstract] [Full Text] [Related]

  • 17. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K.
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [Abstract] [Full Text] [Related]

  • 18. Cryoprecipitate as a reliable source of fibrinogen replacement.
    Ness PM, Perkins HA.
    JAMA; 1979 Apr 20; 241(16):1690-1. PubMed ID: 430729
    [Abstract] [Full Text] [Related]

  • 19. Fibrin glue from stored human plasma. An inexpensive and efficient method for local blood bank preparation.
    Spotnitz WD, Mintz PD, Avery N, Bithell TC, Kaul S, Nolan SP.
    Am Surg; 1987 Aug 20; 53(8):460-2. PubMed ID: 2440358
    [Abstract] [Full Text] [Related]

  • 20. In vitro efficacy of RiaSTAP after rapid reconstitution.
    Karri JV, Cardenas JC, Johansson PI, Matijevic N, Cotton BA, Wade CE, Holcomb JB.
    J Surg Res; 2014 Aug 20; 190(2):655-61. PubMed ID: 24602482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.